Home › Funds › Paradigm Biocapital Advisors LP › TLGYF

Paradigm Biocapital Advisors LP position in TLGYF

TCGX ACQUISITION CORP

Paradigm Biocapital Advisors LP reported holding 300,000 shares of TLGYF (TCGX ACQUISITION CORP) in its Q3 2026 13F filing — a position valued at US$3.8M, representing 0.07% of its reported portfolio and ranking #28 among its reported holdings. Paradigm Biocapital Advisors LP first reported this position in Q3 2026.

Latest position (Q3 2026)300.00K sh
Reported value held$3.75M
Portfolio Weight0.07%
First reportedQ3 2026
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Paradigm Biocapital Advisors LP's TLGYF position evolved

Paradigm Biocapital Advisors LP first disclosed a stake in TLGYF in Q3 2026 at 300,000 shares (US$3.8M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 300.00K $3.75M New

About TLGYF and 13F data

TLGYF (TCGX ACQUISITION CORP) is a company whose sector is not yet classified in our data. 21 other funds we track also report a position in TLGYF — the largest reported positions include Spruce Street Capital LP (US$3.8M), EcoR1 Capital, LLC (US$3.1M), Trails Edge Capital Partners, LP (US$3.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TLGYF

All TLGYF fund holders →

FAQ

How long has Paradigm Biocapital Advisors LP held TLGYF?

Paradigm Biocapital Advisors LP has disclosed TLGYF holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Paradigm Biocapital Advisors LP's current position in TLGYF?

As of Q3 2026, Paradigm Biocapital Advisors LP holds 300.00K shares of TLGYF (TCGX ACQUISITION CORP), valued at $3.75M, representing 0.07% of its reported portfolio and ranking #28.

Has Paradigm Biocapital Advisors LP been buying or selling TLGYF?

In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP newly opened its position in TLGYF.

Which other funds hold TLGYF?

Other major institutional holders of TLGYF include Spruce Street Capital LP, EcoR1 Capital, LLC, Trails Edge Capital Partners, LP, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.